Search results
Author(s):
Dae-Hyun Lee
,
José M de la Torre Hernández
Added:
3 years ago
When Andreas Grüntzig introduced balloon coronary angioplasty in 1977 it represented the first alternative to coronary artery bypass graft surgery. However, balloon dilatation had inherent limitations – including elastic recoil and vessel closure in the acute phase, as well as negative remodelling and restenosis in the late phase – which limited its applicability and further expansion. In the…
View more
Author(s):
Carlo Zivelonghi
,
Giulia Geremia
,
Michele Pighi
,
et al
Added:
3 years ago
Drug-eluting stents (DESs) have significantly improved the effectiveness of percutaneous revascularisation procedures. Since the initial experiences with the first devices, now called ‘first-generation’, DESs have proved very effective in reducing restenosis.1–3 The ‘second-generation’ DESs were conceived to have at least the same standards of efficacy than their predecessors, but with improved…
View more
Author(s):
Ashok Seth
Added:
3 years ago
“I do not know what I may appear to the world, but to myself I seem to have been only like a boy playing on the sea-shore, diverting myself in now and then finding a smoother pebble or a prettier shell than ordinary, whilst the great ocean of truth lay all undiscovered before me.” Sir Isaac Newton
Advances in Percutaneous Coronary Intervention – An Overview
Over the last 10 years, the…
View more
Author(s):
Tamara García Camarero
,
José M de la Torre Hernández
Added:
3 years ago
The use of dual antiplatelet therapy (DAPT) after stent implantation in a percutaneous coronary intervention (PCI) is the standard treatment. The first randomised controlled trial (RCT) to establish the superiority of DAPT versus oral anticoagulant treatment among patients undergoing PCI was the Intracoronary Stenting and Antithrombotic Regimen (ISAR) trial, published in 1996.1 Since then, more…
View more
Author(s):
Savio D’Souza
,
Giuseppe Ferrante
,
Pawel Tyczynski
,
et al
Added:
3 years ago
Percutaneous coronary intervention (PCI) deploying metallic stents is now a standard and routine procedure for the treatment of flow-limiting coronary stenosis in patients with ischaemic heart disease and is an alternative to surgery. Stents were invented to overcome limitations of balloon angioplasty coronary dissections, acute and subacute elastic recoil, intimal hyperplasia and negative vessel…
View more
BIO-RESORT: 5Y Outcomes
Author(s):
Eline H Ploumen
Added:
2 years ago
Video
Patrick W Serruys
Research Area(s) / Expertise:
Author
Craig Thompson
Job title: Director
Author
Foreword
Author(s):
Cesare Rusconi
Added:
3 years ago
Article
Author(s):
Michael Mæng
Added:
1 year ago
In this short interview, Dr Matthew Mæng (Aarhus University Hospital, DK) joins us to discuss the outcomes of a follow-up study on OCT SORT-OUT VIII (NCT02253108), originally presented at EuroPCR 2022.
This follow-up study aimed to compare the outcomes of Boston Scientific's SYNERGY™ stent to the BioMatrix NeoFlex stent.
Findings suggest that the SYNERGY™ stent was non-inferior to the BioMatrix…
View more